213 related articles for article (PubMed ID: 30214040)
1. mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
Wang HY; MacDonald ML; Borgmann-Winter KE; Banerjee A; Sleiman P; Tom A; Khan A; Lee KC; Roussos P; Siegel SJ; Hemby SE; Bilker WB; Gur RE; Hahn CG
Mol Psychiatry; 2020 Apr; 25(4):750-760. PubMed ID: 30214040
[TBL] [Abstract][Full Text] [Related]
2. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.
Matosin N; Fernandez-Enright F; Fung SJ; Lum JS; Engel M; Andrews JL; Huang XF; Weickert CS; Newell KA
Acta Neuropathol; 2015 Jul; 130(1):119-29. PubMed ID: 25778620
[TBL] [Abstract][Full Text] [Related]
3. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.
Banerjee A; Wang HY; Borgmann-Winter KE; MacDonald ML; Kaprielian H; Stucky A; Kvasic J; Egbujo C; Ray R; Talbot K; Hemby SE; Siegel SJ; Arnold SE; Sleiman P; Chang X; Hakonarson H; Gur RE; Hahn CG
Mol Psychiatry; 2015 Sep; 20(9):1091-100. PubMed ID: 25330739
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
Matosin N; Fernandez-Enright F; Lum JS; Andrews JL; Engel M; Huang XF; Newell KA
Schizophr Res; 2015 Aug; 166(1-3):212-8. PubMed ID: 26048293
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.
Isherwood SN; Robbins TW; Dalley JW; Pekcec A
J Neurochem; 2018 Apr; 145(2):111-124. PubMed ID: 29315577
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Metabotropic Glutamate Receptor Internalization and Synaptic AMPA Receptor Endocytosis by the Postsynaptic Protein Norbin.
Ojha P; Pal S; Bhattacharyya S
J Neurosci; 2022 Feb; 42(5):731-748. PubMed ID: 34907024
[TBL] [Abstract][Full Text] [Related]
7. A novel Ca2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons.
Yang L; Mao L; Tang Q; Samdani S; Liu Z; Wang JQ
J Neurosci; 2004 Dec; 24(48):10846-57. PubMed ID: 15574735
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A₂A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation.
Sarantis K; Tsiamaki E; Kouvaros S; Papatheodoropoulos C; Angelatou F
J Neurochem; 2015 Nov; 135(4):714-26. PubMed ID: 26303340
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.
Matosin N; Frank E; Deng C; Huang XF; Newell KA
Schizophr Res; 2013 May; 146(1-3):170-6. PubMed ID: 23462049
[TBL] [Abstract][Full Text] [Related]
10. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
Akkus F; Treyer V; Ametamey SM; Johayem A; Buck A; Hasler G
Schizophr Res; 2017 May; 183():95-101. PubMed ID: 27847228
[TBL] [Abstract][Full Text] [Related]
12. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
[TBL] [Abstract][Full Text] [Related]
13. Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.
Matosin N; Fernandez-Enright F; Lum JS; Newell KA
Neuropharmacology; 2017 Mar; 115():73-91. PubMed ID: 26349010
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.
Matosin N; Newell KA
Neurosci Biobehav Rev; 2013 Mar; 37(3):256-68. PubMed ID: 23253944
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia.
Funk AJ; Mielnik CA; Koene R; Newburn E; Ramsey AJ; Lipska BK; McCullumsmith RE
Schizophr Bull; 2017 Jul; 43(4):891-899. PubMed ID: 28126896
[TBL] [Abstract][Full Text] [Related]
16. A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.
Lum JS; Millard SJ; Huang XF; Ooi L; Newell KA
J Psychiatry Neurosci; 2018 Mar; 43(2):102-110. PubMed ID: 29481317
[TBL] [Abstract][Full Text] [Related]
17. Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.
Verpelli C; Dvoretskova E; Vicidomini C; Rossi F; Chiappalone M; Schoen M; Di Stefano B; Mantegazza R; Broccoli V; Böckers TM; Dityatev A; Sala C
J Biol Chem; 2011 Oct; 286(40):34839-50. PubMed ID: 21795692
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia.
de Bartolomeis A; Vellucci L; De Simone G; Mazza B; Barone A; Ciccarelli M
Cells; 2023 Feb; 12(4):. PubMed ID: 36831241
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.
Kimoto S; Glausier JR; Fish KN; Volk DW; Bazmi HH; Arion D; Datta D; Lewis DA
Schizophr Bull; 2016 Mar; 42(2):396-405. PubMed ID: 26424323
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function.
Uematsu K; Heiman M; Zelenina M; Padovan J; Chait BT; Aperia A; Nishi A; Greengard P
J Neurochem; 2015 Mar; 132(6):677-86. PubMed ID: 25639954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
